The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

5-Fluorocytosine: An Oral Antifungal Compound: A Report on Clinical and Laboratory Experience

[+] Article and Author Information

▸Requests for reprints should be addressed to Theodore C. Eickhoff, M.D., Department of Medicine, University of Colorado Medical Center, Denver, Colo. 80220

Denver, Colorado

Ann Intern Med. 1972;76(1):15-22. doi:10.7326/0003-4819-76-1-15
Text Size: A A A

5-Fluorocytosine, an antifungal drug with potential chemotherapeutic value, was evaluated to determine its in vitro activity against recently isolated fungal strains and was used to treat 17 patients with proved fungal infections. Ninety-two percent of Candida albicans strains, 90% of other Candida species, 83% of Torulopsis glabrata strains, and 28% of strains of Aspergillus species were inhibited by 1.95 µg/ml or less. Therapy with 5-fluorocytosine was usually successful in abdominal infections and persistent fungemia if abscesses and fistulas were drained. Candida and torulopsis pyelonephritides were almost always refractory to 5-fluorocytosine therapy; most patients with these diseases had far-advanced disease and intrarenal abscesses. Two patients with cryptococcal meningitis were not cured with 5-fluorocytosine therapy but had probably received inadequate doses. Other fungal infections responded variably. Two patients had reversible hepatotoxicity related to 5-fluorocytosine therapy. 5-Fluorocytosine may prove to be an effective alternative drug in the treatment of cryptococcus, candida, and torulopsis infections.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Candida infections and their prevention. ISRN Preventive Med 2013;2013():763628.

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.